PureTech Health PLC Transaction in Own Shares (8566K)
May 10 2022 - 3:41AM
UK Regulatory
TIDMPRTC
RNS Number : 8566K
PureTech Health PLC
10 May 2022
9 May 2022
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has
purchased the following number of its ordinary shares of one pence
each through Jefferies International Limited ("Jefferies"), as part
of its Share Buyback Programme, details of which were announced on
9 May 2022.
Date of purchase: 9 May 2022
Number of ordinary shares purchased: 29,545
Highest price paid per share: 170.20p
Lowest price paid per share: 161.00p
Volume weighted average price paid per
share: 163.88p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 29,545
ordinary shares in treasury and has 287,871,859 ordinary shares in
issue (excluding treasury shares). The total number of voting
rights in the Company is therefore 287,871,859, which may be used
by shareholders in their calculations to determine if they are
required to notify their interest in, or a change to their interest
in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No
596/2014 (as incorporated into UK domestic law by the European
Union (Withdrawal) Act 2018) (the Market Abuse Regulation),
detailed information about the individual purchases is available
below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated
to discovering, developing and commercializing highly
differentiated medicines for devastating diseases, including
inflammatory, fibrotic and immunological conditions, intractable
cancers, lymphatic and gastrointestinal diseases and neurological
and neuropsychological disorders, among others. The Company has
created a broad and deep pipeline through the expertise of its
experienced research and development team and its extensive network
of scientists, clinicians and industry leaders.
This pipeline, which is being advanced both internally and
through PureTech's Founded Entities, is comprised of 27
therapeutics and therapeutic candidates, including two that have
received both U.S. FDA clearance and European marketing
authorization, as of the date of PureTech's most recently filed
Annual Report and corresponding Form 6-K. All of the underlying
programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and
then advanced by the PureTech team through key validation points
based on unique insights in immunology and drug development.
For more information, visit www.puretechhealth.com or connect
with us on Twitter @puretechh.
Individual Transactions
Transaction Transaction Volume Price Platform Transaction Reference
Date Time (GBp) Number
9/5/2022 16:27:41 27 164.4 XLON 00299880486TRLO0.1.1
9/5/2022 16:26:58 436 164 XLON 00299879966TRLO0.1.1
9/5/2022 16:22:44 292 164 XLON 00299876299TRLO0.1.1
9/5/2022 16:20:20 518 162.8 XLON 00299874463TRLO0.1.1
9/5/2022 16:19:08 423 162.8 XLON 00299873695TRLO0.1.1
9/5/2022 16:16:46 599 162 XLON 00299872485TRLO0.1.1
9/5/2022 16:14:29 327 162 XLON 00299871132TRLO0.1.1
9/5/2022 16:12:10 322 162 XLON 00299870130TRLO0.1.1
9/5/2022 16:10:04 322 162 XLON 00299869061TRLO0.1.1
9/5/2022 16:08:05 60 161.8 XLON 00299868137TRLO0.1.1
9/5/2022 16:08:05 248 161.8 XLON 00299868136TRLO0.1.1
9/5/2022 16:05:42 324 162 XLON 00299867005TRLO0.1.1
9/5/2022 16:03:24 324 162 XLON 00299866083TRLO0.1.1
9/5/2022 15:54:55 91 163.2 XLON 00299862758TRLO0.1.1
9/5/2022 15:54:55 206 163.2 XLON 00299862757TRLO0.1.1
9/5/2022 15:49:07 378 161.8 XLON 00299860673TRLO0.1.1
9/5/2022 15:45:46 309 161.8 XLON 00299859443TRLO0.1.1
9/5/2022 15:43:33 327 161.8 XLON 00299858682TRLO0.1.1
9/5/2022 15:39:53 135 161.8 XLON 00299857450TRLO0.1.1
9/5/2022 15:39:53 183 161.8 XLON 00299857449TRLO0.1.1
9/5/2022 15:37:50 263 162 XLON 00299856600TRLO0.1.1
9/5/2022 15:33:59 258 161.4 XLON 00299855088TRLO0.1.1
9/5/2022 15:32:01 42 162.2 XLON 00299854205TRLO0.1.1
9/5/2022 15:32:01 216 162.2 XLON 00299854204TRLO0.1.1
9/5/2022 15:29:59 328 162.4 XLON 00299853217TRLO0.1.1
9/5/2022 15:29:59 984 162.4 XLON 00299853216TRLO0.1.1
9/5/2022 15:15:40 304 161.6 XLON 00299847329TRLO0.1.1
9/5/2022 15:12:26 18 161.6 XLON 00299846025TRLO0.1.1
9/5/2022 15:10:04 296 162 XLON 00299845009TRLO0.1.1
9/5/2022 15:10:04 271 162 XLON 00299845008TRLO0.1.1
9/5/2022 15:10:04 313 162 XLON 00299845006TRLO0.1.1
9/5/2022 15:10:04 270 162 XLON 00299845007TRLO0.1.1
9/5/2022 15:10:04 273 162 XLON 00299845005TRLO0.1.1
9/5/2022 15:10:04 136 162 XLON 00299845004TRLO0.1.1
9/5/2022 15:10:04 273 162 XLON 00299845003TRLO0.1.1
9/5/2022 15:10:04 29 162 XLON 00299845002TRLO0.1.1
9/5/2022 15:10:04 108 162 XLON 00299845001TRLO0.1.1
9/5/2022 14:46:19 507 162.8 XLON 00299834214TRLO0.1.1
9/5/2022 14:41:42 305 164.2 XLON 00299832373TRLO0.1.1
9/5/2022 14:39:06 257 164.8 XLON 00299831239TRLO0.1.1
9/5/2022 14:36:59 315 165 XLON 00299830208TRLO0.1.1
9/5/2022 14:36:59 315 165 XLON 00299830207TRLO0.1.1
9/5/2022 14:34:59 315 165.4 XLON 00299829304TRLO0.1.1
9/5/2022 14:26:43 300 162.4 XLON 00299825449TRLO0.1.1
9/5/2022 14:21:48 1938 162.8 XLON 00299824202TRLO0.1.1
9/5/2022 14:21:48 323 162.8 XLON 00299824201TRLO0.1.1
9/5/2022 13:38:45 268 161 XLON 00299813109TRLO0.1.1
9/5/2022 13:28:48 319 162.4 XLON 00299810723TRLO0.1.1
9/5/2022 13:21:21 300 162.8 XLON 00299809024TRLO0.1.1
9/5/2022 13:15:46 400 162.8 XLON 00299807569TRLO0.1.1
9/5/2022 13:04:46 429 163 XLON 00299804912TRLO0.1.1
9/5/2022 13:00:06 301 163 XLON 00299803848TRLO0.1.1
9/5/2022 12:47:10 355 163 XLON 00299800934TRLO0.1.1
9/5/2022 12:40:34 79 163.4 XLON 00299799330TRLO0.1.1
9/5/2022 12:40:34 232 163.4 XLON 00299799329TRLO0.1.1
9/5/2022 12:33:41 222 163.4 XLON 00299797692TRLO0.1.1
9/5/2022 12:33:41 72 163.4 XLON 00299797691TRLO0.1.1
9/5/2022 12:23:30 528 163.4 XLON 00299795276TRLO0.1.1
9/5/2022 12:10:51 408 163.4 XLON 00299792405TRLO0.1.1
9/5/2022 12:10:51 94 163.4 XLON 00299792404TRLO0.1.1
9/5/2022 12:04:52 304 163.4 XLON 00299791055TRLO0.1.1
9/5/2022 11:55:42 34 163 XLON 00299788911TRLO0.1.1
9/5/2022 11:55:42 91 163 XLON 00299788910TRLO0.1.1
9/5/2022 11:55:42 195 163 XLON 00299788909TRLO0.1.1
9/5/2022 11:47:56 301 163 XLON 00299787156TRLO0.1.1
9/5/2022 11:38:46 391 163.4 XLON 00299784783TRLO0.1.1
9/5/2022 11:31:58 103 164.6 XLON 00299783222TRLO0.1.1
9/5/2022 11:31:58 122 164.6 XLON 00299783224TRLO0.1.1
9/5/2022 11:31:58 103 164.4 XLON 00299783221TRLO0.1.1
9/5/2022 11:28:07 313 164.2 XLON 00299782196TRLO0.1.1
9/5/2022 11:23:43 322 164.2 XLON 00299781225TRLO0.1.1
9/5/2022 11:23:43 261 164.2 XLON 00299781224TRLO0.1.1
9/5/2022 11:23:43 296 164.2 XLON 00299781223TRLO0.1.1
9/5/2022 11:23:40 26 164.2 XLON 00299781190TRLO0.1.1
9/5/2022 10:50:39 38 163.8 XLON 00299772941TRLO0.1.1
9/5/2022 10:50:39 464 163.8 XLON 00299772940TRLO0.1.1
9/5/2022 10:48:33 268 164.2 XLON 00299772432TRLO0.1.1
9/5/2022 10:48:33 1072 164.2 XLON 00299772431TRLO0.1.1
9/5/2022 10:08:08 191 163.8 XLON 00299761342TRLO0.1.1
9/5/2022 10:08:08 268 164.2 XLON 00299761343TRLO0.1.1
9/5/2022 09:57:56 383 164.8 XLON 00299758703TRLO0.1.1
9/5/2022 09:53:13 453 164.8 XLON 00299757391TRLO0.1.1
9/5/2022 09:53:13 89 164.8 XLON 00299757390TRLO0.1.1
9/5/2022 09:51:20 263 164.8 XLON 00299756943TRLO0.1.1
9/5/2022 09:32:36 297 163.6 XLON 00299751082TRLO0.1.1
9/5/2022 09:30:10 311 164.4 XLON 00299750164TRLO0.1.1
9/5/2022 09:21:17 330 165.6 XLON 00299747673TRLO0.1.1
9/5/2022 09:12:38 324 168 XLON 00299745226TRLO0.1.1
9/5/2022 09:06:37 114 168 XLON 00299743294TRLO0.1.1
9/5/2022 09:06:37 197 168 XLON 00299743293TRLO0.1.1
9/5/2022 09:06:37 16 168 XLON 00299743292TRLO0.1.1
9/5/2022 09:03:46 268 170 XLON 00299742240TRLO0.1.1
9/5/2022 09:03:46 457 170.2 XLON 00299742238TRLO0.1.1
9/5/2022 09:03:46 117 170.2 XLON 00299742239TRLO0.1.1
9/5/2022 09:03:46 929 170.2 XLON 00299742237TRLO0.1.1
9/5/2022 09:03:44 264 170.2 XLON 00299742216TRLO0.1.1
9/5/2022 09:03:44 465 170.2 XLON 00299742215TRLO0.1.1
9/5/2022 09:03:44 36 170.2 XLON 00299742214TRLO0.1.1
9/5/2022 09:03:31 254 170.2 XLON 00299742138TRLO0.1.1
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSFLFLTEIIAIIF
(END) Dow Jones Newswires
May 10, 2022 03:41 ET (07:41 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024
